Your Gout Guide for ACR Convergence 2024: Dr. Lisa Stamp

Dr. Lisa Stamp

ACR Convergence 2024 is just around the corner. The annual meeting will be held Nov. 14–19, at the Walter E. Washington Convention Center in Washington, D.C. If the thought of sorting through thousands of research abstracts and papers feels overwhelming, you’re not alone. Fortunately, Lisa Stamp, MBChB, PhD, is here to help the busy clinician by curating a collection of the most significant and notable abstracts in gout research.

Dr. Stamp is a rheumatologist and professor of medicine at the University of Otago in Christchurch, New Zealand, as well as the clinical lead for research at Health New Zealand. She is the recipient of several prestigious honors, including the Arthritis New Zealand National Researcher Award. Dr. Stamp has extensively researched the pathophysiology and management of gout. 

Dr. Stamp’s own research focuses on refining current treatments for rheumatic diseases broadly and gout in particular. She has conducted pharmacokinetic and pharmacogenetic studies concerning allopurinol, the standard for urate-lowering therapy for gout. Her clinical research repertoire also includes clinical trials related to methotrexate, a crucial drug in the management of rheumatoid arthritis.

You can learn more about Dr. Stamp’s work and credentials here.

This will be the third year The Rheumatologist has published Dr. Stamp’s top picks in gout research. Watch this space, where Dr. Stamp will summarize elaborate on the relevance of each selection.